Answer
Yes, ripretinib (QINLOCK) can cause hand-foot syndrome (palmar-plantar erythrodysaesthesia), reported in 29.8% of 392 patients in the pooled safety population, including Grade 3 reactions in 0.5%.
Sources for this answer
- QINLOCK 50 mg tabletsDeciphera · emc · SmPC §4.8 Undesirable effects · Version 2Document updated
Sources checked